Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
92%
Disease
66%
Rheumatoid Arthritis
63%
Inflammatory Arthritis
63%
Anticoagulant Agent
55%
Aortic Valve Stenosis
45%
Antiarrhythmic Agent
45%
Warfarin
44%
Cardiovascular Risk
42%
Recurrent Disease
40%
Biological Marker
36%
Prevalence
35%
Chronic Thromboembolic Pulmonary Hypertension
31%
Infection
31%
Cytokine
29%
Dysglycemia
28%
Cardiovascular Disease
28%
Human Parvovirus B19
28%
Omega-3 Fatty Acid
25%
Amiodarone
25%
Insulin Glargine
22%
Heart Arrhythmia
21%
Tumor Necrosis Factor
20%
Dabigatran
20%
Rivaroxaban
20%
Polyp
19%
Malonaldehyde
19%
Coronary Artery Disease
19%
Interleukin 6
18%
Hypertension
18%
Heart Infarction
18%
Multiple Myeloma
18%
Rheumatoid Factor
18%
Ischemic Heart Disease
18%
Coronary Artery Occlusion
18%
Beta Adrenergic Receptor Blocking Agent
17%
Recurrence Risk
17%
Cerebrovascular Accident
17%
Non Insulin Dependent Diabetes Mellitus
16%
Disease Activity
16%
Chemerin
16%
Inflammation
16%
Prospective Study
15%
Fatty Acid
15%
Drug-Drug Interaction
15%
Congestive Heart Failure
14%
Direct Oral Anticoagulant
14%
Diabetes Mellitus
14%
Stenosis
14%
C Reactive Protein
13%
Medicine and Dentistry
Disease
64%
Chronic Thromboembolic Pulmonary Hypertension
57%
Cardiovascular System
48%
Rheumatoid Arthritis
46%
Inflammatory Arthritis
46%
Osteoarthritis
45%
Bone Density
43%
Cardiovascular Risk
42%
Prevalence
42%
Infection
37%
Immunoglobulin A Nephropathy
36%
Atrial Fibrillation
36%
Colonoscopy
31%
Cross Sectional Study
31%
Body Mass Index
30%
Percutaneous Coronary Intervention
28%
B Cell
27%
Parvovirus B19
27%
Aortic Valve Stenosis
27%
Cardiac Resynchronization Therapy
27%
Cardiovascular Disease
24%
Iodine Deficiency
24%
Pulmonary Hypertension
22%
Pleura Effusion
20%
Diabetes
20%
Recurrent Disease
19%
Effusion
19%
Insulin Glargine
19%
Dysglycemia
19%
Diagnosis
19%
Rheumatoid Factor
19%
Right Ventricle
19%
Polyp
18%
Keratosis
18%
Continuous Hemofiltration
18%
Coronary Occlusion
18%
Edentulousness
18%
Cohort Effect
18%
Cytokine
18%
Multiple Myeloma
18%
Kidney Graft
18%
Cardioversion
18%
Angioplasty
18%
Plasminogen Activator Inhibitor-1
18%
Sleep Quality
18%
Melatonin
18%
Patient with Type 2 Diabetes
18%
Table Salt
17%
Congestive Heart Failure
16%
Knee
16%
Immunology and Microbiology
Inflammatory Arthritis
100%
Human Parvovirus B19
45%
Aortic Valve
45%
IgA Nephropathy
36%
Blood Plasma
35%
B Cell
30%
Cytokine
29%
Interleukin 6
26%
Osteoarthritis
25%
Immunoglobulin A
23%
Body Mass
22%
Insulin Resistance
21%
Chemerin
20%
Coronary Artery
20%
Adiponectin
19%
Peripheral Blood Mononuclear Cell
18%
Human Herpesvirus 6
18%
Rheumatoid Factor
18%
Human Herpesvirus 7
18%
Tumor Necrosis Factor Alpha
16%
Lymphocyte
15%
Immunology
15%
Fibroblast Growth Factor 21
14%
Immunoglobulin M
13%
Synovial Fluid
12%
Cell Population
12%
Prevalence
12%
Thyroid
10%
Cell Function
10%
Glomerulus Filtration
9%
CD19
9%
C-Reactive Protein
9%
Human Immunodeficiency Virus 1
9%
Adipokine
9%
Immune Response
9%
Enterobacteriaceae
9%
JC Virus
9%
Mycobacterium Tuberculosis
9%
Intestine Preparation
9%
Creatinine Blood Level
9%
Iodine Deficiency
9%
Complement Component 3
9%
Complement Component 4
9%
Autoimmune Thyroiditis
9%
Heart Ejection Fraction
9%
Interferon Gamma
9%
Electrocardiogram
9%
Long Term Survival
9%
Complement
9%
Growth Factor
9%